Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 202

The DOI matches its Crossref record.

Outcomes and Cost-effectiveness of Initiating Dialysis and Continuing Aggressive Care in Seriously Ill Hospitalized Adults

Hamel, Mary Beth, Phillips, Russell S., Davis, Roger B., Desbiens, Norman, Connors Jr., Alfred F., Teno, Joan M., Wenger, Neil, Lynn, Joanne, Wu, Albert W., Fulkerson, William, Tsevat, Joel · 1997 · Annals of Internal Medicine

Abstract

BACKGROUND: Renal failure requiring dialysis in the setting of hospitalization for serious illness is a poor prognostic sign, and dialysis and aggressive care are sometimes withheld. OBJECTIVE: To evaluate the clinical outcomes and cost-effectiveness of initiating dialysis and continuing aggressive care for seriously ill hospitalized patients. DESIGN: Prospective cohort study and cost-effectiveness analysis. SETTING: Five geographically diverse teaching hospitals. PATIENTS: 490 patients (median age, 61 years; 58% women) enrolled in the Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments (SUPPORT) in whom dialysis was initiated. MEASUREMENTS: Survival, functional status, quality of life, and health care costs. Life expectancy was estimated by extrapolating survival data (up to 4.4 years of follow-up) using a declining exponential function. Utilities (quality-of-life weights) were estimated by using time-tradeoff questions. Costs were based on data from SUPPORT and published Medicare data. RESULTS: Median duration of survival was 32 days, and only 27% of patients were alive after 5 months. Survivors reported a median of one dependency in activities of daily living, and 62% rated their quality of life as "good" or better. Overall, the estimated cost per quality-adjusted life-year saved by initiating dialysis and continuing aggressive care rather than withholding dialysis and allowing death to occur was $128,200. For the 103 patients in the worst prognostic category, the estimated cost per quality-adjusted life-year was $274,100; for the 94 patients in the best prognostic category, the cost per quality-adjusted life-year was $61,900. CONCLUSIONS: For the few patients who survived, clinical outcomes were fairly good. With the exception of patients with the best prognoses, however, the cost-effectiveness of initiating dialysis and continuing aggressive care far exceeded $50,000 per quality-adjusted life-year, a commonly cited threshold for cost-effective care.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.7326/0003-4819-127-3-199708010-00003

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 202

Metadata

Authors
Hamel, M. B., Phillips, R. S., Davis, R. B., Desbiens, N., Connors Jr., A. F., Teno, J. M., Wenger, N., Lynn, J., Wu, A. W., Fulkerson, W., & Tsevat, J.
Venue
Annals of Internal Medicine
Published
1997-08-01
Volume
127
Issue
3
Pages
195-202
ISSN
  • 0003-4819 (ISSN-L)
  • 1539-3704
OpenAlex
W2159927029
Cited by
202
References
0
FWCI
9.66
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Outcomes and Cost-effectiveness of Initiating Dialysis and Continuing Aggressive Care in Seriously Ill Hospitalized Adults. https://app.cochat.ai/papers/10.7326/0003-4819-127-3-199708010-00003
The paper
Hamel, M. B., Phillips, R. S., Davis, R. B., Desbiens, N., Connors Jr., A. F., Teno, J. M., Wenger, N., Lynn, J., Wu, A. W., Fulkerson, W., & Tsevat, J. (1997). Outcomes and Cost-effectiveness of Initiating Dialysis and Continuing Aggressive Care in Seriously Ill Hospitalized Adults. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-127-3-199708010-00003

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.